INOVIO PHARMACEUTICALS, INC.
INO · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Yarno Wendy L: Form 4
Insider disclosure · Filed · Report period 20 May 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001055726 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- INO on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA, 19462
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- INOVIO BIOMEDICAL CORP (to 11 May 2010), GENETRONICS BIOMEDICAL CORP (to 01 Apr 2005), GENETRONICS BIOMEDICAL LTD (to 03 Aug 2001)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields